General MedicationsINJECTIONGeneric
ILOTYCIN GLUCEPTATE
ERYTHROMYCIN GLUCEPTATE
Standard Dose
EQ 250MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview ILOTYCIN GLUCEPTATE is listed in Drugs@FDA under application 050370 (NDA).
Marketing status: Discontinued Active ingredient ERYTHROMYCIN GLUCEPTATE Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/VIAL Sponsor DISTA Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview ILOTYCIN GLUCEPTATE is listed in Drugs@FDA under application 050370 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN GLUCEPTATE Form and strength INJECTABLE;INJECTION - EQ 250MG BASE/VIAL Sponsor DISTA Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.